Daniel J. Lippis Edwards Lifesciences Corp (EW) insider trading activity

Daniel J. Lippis is CVP, JAPAC of Edwards Lifesciences Corp. Currently has a direct ownership of 23,189 shares of EW, which is worth approximately $1.73 Million. The most recent transaction as insider was on Dec 16, 2024, when has been sold 2,500 shares (Common Stock) at a price of $74.08 per share, resulting in proceeds of $185,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.2K

0% 3M change

n/a 12M change

Total Value Held $1.73 Million

Daniel J. Lippis Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 16 2024	SELL Open market or private sale	$185,200 $74.08 p/Share	2,500 Reduced 9.73%	23,189 Common Stock
Dec 16 2024	BUY Exercise of conversion of derivative security	$113,200 $45.28 p/Share	2,500 Added 8.87%	25,689 Common Stock
Jul 11 2024	SELL Open market or private sale	$47,090 $94.18 p/Share	500 Reduced 2.11%	23,189 Common Stock
Jul 11 2024	BUY Exercise of conversion of derivative security	$22,640 $45.28 p/Share	500 Added 2.07%	23,689 Common Stock
Jul 07 2024	SELL Payment of exercise price or tax liability	$37,851 $92.32 p/Share	410 Reduced 1.74%	23,189 Common Stock
Jun 20 2024	SELL Open market or private sale	$48,150 $90.0 p/Share	535 Reduced 2.22%	23,512 Common Stock
Jun 20 2024	BUY Exercise of conversion of derivative security	$24,224 $45.28 p/Share	535 Added 2.18%	24,047 Common Stock
May 11 2024	SELL Payment of exercise price or tax liability	$32,693 $86.72 p/Share	377 Reduced 1.58%	23,512 Common Stock
May 07 2024	SELL Open market or private sale	$73,359 $85.6 p/Share	857 Reduced 3.46%	23,889 Common Stock
May 07 2024	SELL Payment of exercise price or tax liability	$49,862 $85.09 p/Share	586 Reduced 2.31%	24,746 Common Stock
May 07 2024	BUY Exercise of conversion of derivative security	$31,494 $36.75 p/Share	857 Added 3.27%	25,332 Common Stock
May 07 2024	BUY Grant, award, or other acquisition	-	7,560 Added 23.6%	24,475 Common Stock
May 04 2024	SELL Payment of exercise price or tax liability	$24,807 $85.25 p/Share	291 Reduced 1.69%	16,915 Common Stock
May 03 2024	SELL Payment of exercise price or tax liability	$23,901 $85.06 p/Share	281 Reduced 1.61%	17,206 Common Stock
Apr 09 2024	SELL Open market or private sale	$79,135 $92.34 p/Share	857 Reduced 4.67%	17,487 Common Stock
Apr 09 2024	BUY Exercise of conversion of derivative security	$31,494 $36.75 p/Share	857 Added 4.46%	18,344 Common Stock
Mar 07 2024	SELL Open market or private sale	$156,030 $90.98 p/Share	1,715 Reduced 9.06%	17,213 Common Stock
Mar 07 2024	BUY Exercise of conversion of derivative security	$63,026 $36.75 p/Share	1,715 Added 8.31%	18,928 Common Stock
Feb 18 2024	SELL Payment of exercise price or tax liability	$16,186 $86.1 p/Share	188 Reduced 1.08%	17,213 Common Stock
Feb 17 2024	SELL Payment of exercise price or tax liability	$12,915 $86.1 p/Share	150 Reduced 0.85%	17,401 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$17,810 $86.04 p/Share	207 Reduced 1.17%	17,551 Common Stock

DJL

Daniel J. Lippis

CVP, JAPAC

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Value

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW

Account